Hypoxia-inducible factor (HIF) is
Members of the hypoxia-inducible factor (HIF) family of transcription factors are important regulators of adaptive cellular responses to hypoxia, since they regulate the expression of genes that promote angiogenesis, erythropoiesis, anaerobic energy production, and cell survival (4) . Overexpression of HIF is a hallmark of diverse tumors, and its constitutive activation is frequently associated with aggressive tumor phenotypes exhibiting resistance to conventional cancer therapies (4) . HIF is a heterodimer composed of a catalytic ␣ subunit and a common ␤ subunit (also known as ARNT). Whereas ARNT is constitutively expressed and stable, the ␣ subunit (HIF-1␣, HIF-2␣, and HIF-3␣) is oxygen labile (3) . Under normoxic conditions, HIF-␣ subunits are hydroxylated on conserved proline residues by a class of prolyl hydroxylases. The von Hippel-Lindau (VHL) tumor suppressor protein is a substrate recognition component of an E3 ubiquitin ligase that targets prolyl-hydroxylated HIF-␣ for ubiquitin-mediated destruction (22) . Under hypoxic conditions, HIF-␣ remains unmodified by prolyl hydroxylases and thereby escapes recognition by VHL and destruction. The stable HIF-␣ dimerizes with ARNT to initiate the transcription of numerous hypoxia-inducible genes.
Germ line inheritance of a faulty VHL gene causes VHL disease, which is characterized by retinal and cerebellar hemangioblastomas, pheochromocytoma, and renal clear-cell carcinoma (RCC). Tumor development is associated with the loss of the remaining wild-type VHL allele in a susceptible cell. Biallelic inactivation of the VHL locus is also responsible for the development of the majority of sporadic RCC, establishing VHL as the critical "gatekeeper" of the renal epithelium (22) . VHL contains two functional domains: ␣ and ␤. The ␣ domain is required for binding elongin C, which bridges VHL to the rest of the E3 ligase complex. The ␤ domain functions as a protein-protein interaction interface and is necessary and sufficient for binding prolyl-hydroxylated HIF-␣. Tumor-causing mutations frequently map to either domain, which results in the stabilization and accumulation of HIF-␣, suggesting the importance of these domains in the tumor suppressor activity of VHL (37) .
In addition to its role in promoting tumor growth, HIF-␣ has also been implicated in mediating diverse immune responses (12) . For example, accumulation of HIF-␣ promotes the activity of NF-B, a transcription factor that initiates multiple immune functions (2) . Moreover, cytokines such as interleukin 1 beta, tumor necrosis factor alpha, and alpha interferon (IFN-␣) can activate HIF in an oxygen-independent manner (10, 14) . Recently, HIF was shown to be induced and activated by lipopolysaccharide (LPS), a component of gram-negative bacterial cell walls (5) . In a clinical context, the bacterial pathogen Bartonella henselae, which is known to cause vasculoproliferative disorders, also activates HIF under normoxic conditions (17) . The evidence for the involvement of HIF in immunity is not limited to the observations that HIF is acti-vated by pathogens and inflammatory mediators that are produced during immune responses. Oda et al. showed that HIF-1␣ is required for the maturation, activation, and effective infiltration of myeloid cells into sites of infection (27) . Importantly, the loss of HIF-1␣ significantly impaired myeloid cells' ability to kill bacteria (8) . In support, mice lacking HIF-1␣ in their myeloid cell lineage demonstrated reduced bactericidal activity and were unable to control the systemic spread of bacterial infection. The mechanism for this effect is likely due to the ability of HIF-1␣ to regulate the production of immune effector molecules, including granule proteases, antimicrobial peptides, nitric oxide, and tumor necrosis factor alpha (31) . These findings demonstrate a role for HIF-␣ in mediating antibacterial responses in myeloid cells.
A diverse array of innate immune response mechanisms is initiated upon host cell recognition of conserved virus-associated molecular patterns, such as double-stranded RNA (dsRNA) and single-stranded RNA. dsRNA is recognized by cellular receptors, including dsRNA-dependent protein kinase (20) , Toll-like receptor 3 (TLR3), RIG-1, and Mda-5 (39) . In contrast, single-stranded RNA is recognized by TLR7 and TLR8 (35) . Upon recognition of these virus motifs, distinct signaling events are initiated in the host cell, resulting in the activation of specific transcription factors, such as NF-B and IRF3 (35) . These factors in turn mediate striking transcriptional changes within the host cell, including the upregulation of numerous cytokines, such as beta interferon (IFN-␤), as well as chemokines and mediators of adaptive immune responses (33) . The responses collaboratively function to limit virus replication, recruit immune cells to the site of infection, and direct subsequent adaptive immune responses.
IFNs comprise one family of cytokines that is commonly induced in host cells upon recognition of viral infection. They play key roles not only in promoting antiviral responses but also in mediating antiproliferative, immunoregulatory, and apoptotic activities. IFNs initiate autocrine and paracrine cellular signaling events by binding to their respective cell surface receptors, causing activation of the JAK/STAT pathway through specific phosphorylation and dimerization events. The STAT transcription factors then participate in upregulating the expression of numerous downstream IFN-stimulated genes (ISGs). The antiviral mechanisms of some ISGs are well characterized. For example, in response to viral dsRNA, oligoadenylate synthetase 1 (OAS1) functions to limit virus replication by forming short 2Ј-5Ј oligoadenylate strands, which in turn cause the enzyme RNase L to cleave both cellular and viral RNAs (24) . Vesicular stomatitis virus (VSV) is a single-stranded RNA virus belonging to the Rhabdoviridae family which causes cytolytic infections in mammals. It is highly sensitive to the antiviral effects of type 1 IFNs (36) and therefore has often been used as an ideal experimental model system to investigate the pathogenesis of virus infections and innate antiviral immunity (13) . Here, we investigate the role of HIF-␣ in the antiviral response to VSV infection and show that VSV replication and cytolysis is dramatically inhibited by HIF-␣ activity. The 786-O (VHL Ϫ/Ϫ ) RCC cells, which have constitutive HIF activity, are more resistant to the cytolytic effect of VSV than RCC cells expressing wild-type VHL with low basal HIF activity. Similarly, RCC cells expressing a disease-associated VHL(Y112H) mutant that is unable to down-regulate HIF-␣ are more resistant to VSV than RCC cells expressing another disease-associated VHL(L188V) mutant that nevertheless retain the ability to target HIF-␣ for degradation. Chetomin, a small-molecule 
MATERIALS AND METHODS
Cell culture. Human 786-O RCC cells and 786-O subclones stably expressing hemagglutinin (HA)-tagged wild-type VHL (786-VHL) or mutant VHL(L188V) were previously described (15, 18, 29, 30) . A 786-O subclone stably expressing the VHL(Y112H) mutant was generated as described previously (15) . 786-O cells stably expressing scrambled short-hairpin RNA (shRNA) or shRNA targeting HIF-2␣ were generously provided by William Kaelin (19) . Human T98G glioblastoma cells and mouse L929 fibroblasts were obtained from American Type Culture Collection (Rockville, MD). All cells were cultured in antibioticfree Dulbecco's modified Eagle's medium (DMEM) plus 10% fetal bovine serum (FBS) (HyClone) and maintained at 37°C in a humidified 5%-CO 2 atmosphere.
Antibodies. Monoclonal anti-␣-tubulin was obtained from Sigma (Oakville, Ontario, Canada). Monoclonal anti-HA (12CA5) was obtained from Roche Molecular Biochemicals (Mannheim, Germany). Monoclonal anti-HIF-1␣ was obtained from NOVUS Biologicals (Littleton, CO). Monoclonal anti-VHL antibody was obtained from BD Pharmingen (Mississauga, Ontario, Canada). Neutralizing mouse anti-human IFN-␣/␤ receptor chain 2 (CD118) antibody was obtained from PBL Biomedical Laboratories (Piscataway, NJ).
Immunoprecipitation and immunoblotting. Immunoprecipitation and immunoblottting were performed as described previously (28) .
Trypan blue cell viability assay. Cells were seeded at a density of 1 ϫ 10 5 cells per well (total volume, 2 ml) in six-well plates and incubated overnight in DMEM supplemented with 10% FBS. Cells were infected with VSV (multiplicity of infection [MOI] ϭ 0.1) obtained from the American Type Culture Collection (Rockville, MD). The cells were washed once with phosphate-buffered saline (PBS) 2 h postinfection, and DMEM with 10% FBS was replaced. They were then washed once with PBS at the indicated time point and were trypsinized and resuspended in trypan blue stain (0.4%) (Gibco-Invitrogen, Burlington, Ontario, Canada). The number of live cells excluding the dye was determined under a light microscope using a hemocytometer. Experiments were performed in triplicate.
Interferon protection assay. 786-O, 786-VHL, 786-Y112H, or 786-L188V cells were plated in 96-well plates at a density of 2 ϫ 10 4 cells per well and were incubated overnight at 37°C. They were treated with twofold serial dilutions of IFN-␣2b, starting from 100 U/ml, and incubated for 18 h. The cells were then treated with VSV (MOI ϭ 0.02) for 40 h in DMEM plus 0.5% FBS and stained with 0.5% crystal violet to visualize live cells.
Neutralizing antibody assays. 786-O and 786-VHL cells were incubated with 1 g/ml of neutralizing anti-IFN-␣/␤ receptor chain 2 antibody for 30 min prior to conducting a trypan blue cell viability assay or IFN protection assay. Quantification of crystal violet-stained plates. Cells stained with crystal violet were scanned using a SnapScan e50 (Afga) scanner, and the resulting TIFF images were imported into ImageJ (1). The images were converted to 8-bit gray scale, and the "integrated density" of each well was then measured. The "percentage of control" values were calculated by dividing the raw "integrated density" values by the "integrated density" of corresponding untreated control wells. Nonlinear regression was performed on the resulting values using a sigmoidal dose-response model with variable slope equation in GraphPad Prism version 4.0b for Mac (Mac 05 version) (GraphPad Software, San Diego CA).
Virus replication assay. The virus replication assay was performed as previously described (9) . 786-O or 786-VHL cells were plated in six-well plates at a density of 1 ϫ 10 5 cells per well and were incubated overnight in DMEM plus 10% FBS at 37°C. They were treated with VSV (MOI ϭ 0.1) for 2 h. The cells were then washed twice with PBS, and fresh DMEM plus 10% FBS medium was added. At the indicated time points, the cells were harvested and pooled with the supernatant. Cells were lysed by freeze-thaw and vortexing. Fivefold serial dilutions of the resulting lysates were added to L929 mouse fibroblast monolayers in 96-well plates and incubated for 48 h. Live cells were then stained with 0.5% crystal violet to quantify the median tissue culture infective dose.
Chetomin cell viability assay. 786-O or 786-VHL cells were plated in six-well plates at a density of 1 ϫ 10 5 cells per well and incubated overnight. They were then treated with 50 nM chetomin (Alexis Biochemicals, San Diego, CA) for 18 h prior to RNA isolation for real-time quantitative PCR (qPCR) or for 16 h prior to challenge with VSV (MOI ϭ 0.1). Cell viability was quantified by trypan blue exclusion at 12-h intervals postinfection. The experiment was performed in triplicate.
RNA extraction and cDNA synthesis. RNA was isolated using the standard RNeasy Mini kit (QIAGEN, Mississauga, Ontario, Canada) protocol and treated with DNase I (Ambion, Austin, TX) for 30 min to remove residual DNA. RNA concentrations were determined by spectrophotometry, and 2.5 or 5 g of total RNA from each sample was reverse transcribed by oligo(dT) priming. Reverse transcription was performed by incubating the RNA with 1 l of 0.5-g/l oligo(dT) and DNase/RNase-free water (Sigma, Oakville, Ontario, Canada) to a total volume of 11 l at 70°C for 10 min. Four microliters of 5ϫ First Strand buffer, 2 l of 0.1 M dithiothreitol, 1 l of 10 mM deoxynucleoside triphosphates, and 1 l of SuperScript II enzyme (all from Invitrogen, Burlington, Ontario, Canada) were added to the reaction, and the mixture was incubated for 1.5 h at 42°C. The SuperScript was then inactivated by incubating the samples at 70°C for 15 min. These cDNA samples were stored at Ϫ20°C until used in real-time qPCR experiments. Genomic DNA derived from human placenta was used to generate standard curves for each primer tested. The housekeeping gene, ␤-ACTIN or TBP, was used to normalize cDNA loading. Gene-specific oligonucleotide primers designed using Primer Express 2.0 software (Applied Biosystems, Foster City, CA) were as follows: GLUT1 (5Ј-TGC AACGGCTTAGACTTCGA-3Ј and 5Ј-GAGGACACTGATGAGAGGTACG TGTA-3Ј), EDN1 (5Ј-GCCCTCCAGAGAGCGTTATGT-3Ј and 5Ј-CCCGAA GGTCTGTCACCAA-3Ј), IFN␤ (5Ј-AGCAGTCTGCACCTGAAAAGATAT T-3Ј and 5Ј-TGTACTCCTTGGCCTTCAGGTAA-3Ј), IL6 (5Ј-CACTGGGCA CAGAACTTATGTTG-3Ј and 5Ј-AAAATAATTAAAATAGTGTCCTAACG CTCAT-3Ј), OAS-1 (5Ј-TGCTCCATATTTTACAGTCATTTTGG-3Ј and 5Ј-G GACAAGGGATGTGAAAATTCC-3Ј), and IFIT1 (5Ј-AGGCATTAGATCTG GAAAGCTTGA-3Ј and 5Ј-GCTTCATTCATATTTCCTTCCAATTT-3Ј).
RESULTS
HIF-1␣ was identified in microarray studies as being inducible by bacterial LPS and antiviral type I IFNs (10, 11). Therefore, we hypothesized that HIF-␣ not only is involved in mediating innate antibacterial responses but also participates in IFN-dependent antiviral responses.
Loss of VHL results in enhanced resistance to VSV. To test our hypothesis, we examined antiviral responses in 786-O cells, which are RCC cells devoid of functional VHL and which consequently overexpress HIF-␣, as well as 786-O cells ectopically expressing HA-tagged VHL (786-VHL). VHL expression in the parental 786-O and 786-VHL cells was confirmed by anti-HA Western blot analysis (Fig. 1A) . As expected, in com- (Fig. 1B) . 786-O and 786-VHL cells were treated with serial dilutions of IFN-␣2b, followed by challenge with VSV at a MOI of 0.02. VSV effectively killed 786-VHL cells, and IFN treatment provided protection with an effective concentration (EC 50 ) of 3.6 U/ml. Strikingly, 786-O cells were highly resistant to VSV-induced death even in the absence of IFN␣2b ( Fig. 2A) . We next evaluated the cytolytic response to VSV infection by challenging 786-O and 786-VHL cells with wild-type VSV (MOI ϭ 0.1). Live cells were visualized using phase-contrast microscopy and quantified by trypan blue exclusion postinfection. 786-VHL cells were significantly more sensitive to cytolysis than the 786-O cells (Fig. 2B and C) . Whereas VSV killed nearly 100% of the 786-VHL cells by 48 h postinfection, 786-O cells were marginally affected (Fig. 2C) . The level of cytotoxicity was further validated by crystal violet staining and immunoblotting for PARP cleavage (data not shown). The enhanced antiviral resistance observed in 786-O cells was corroborated by restricted virus replication in comparison to VHL-expressing counterpart (Fig. 2D) . At 24 h postinfection, there was approximately a 2-log difference in the VSV titer, with a titer of 5.01 ϫ 10 9 in 786-VHL cells and 3.98 ϫ 10 7 in 786-O cells (Fig. 2D) .
The enhanced antiviral activity of RCC cells is HIF dependent. The negative regulation of HIF via ubiquitin-mediated destruction is the best-characterized function of VHL. Therefore, we next asked whether the observed resistance of VHLnull RCC cells to VSV is HIF dependent. The VHL(L188V) mutant is associated with type 2C VHL disease, which is characterized by the exclusive development of pheochromocytoma without the other stigmata of the disease (28) . It is well documented that VHL(L188V) retains the ability to properly regulate HIF (15), suggesting a HIF-independent function of VHL that is critical for the development of pheochromocytoma. The VHL(Y112H) mutant is associated with type 2A VHL disease, which is characterized by the development of retinal and central nervous system hemangioblastomas, as well as RCC. Like most VHL mutants tested to date, VHL(Y112H) has an impaired ability to regulate HIF due to its inability to bind prolyl-hydroxylated HIF-␣ (6). RCC cells ectopically expressing VHL(Y112H) (786-Y112H) (Fig. 1A) , like the VHLnull 786-O cells, were resistant to VSV-mediated killing even under the lowest-dose IFN-␣ treatment (Fig. 3A) . In contrast, 786-L188V cells (see Fig. 1A ) were sensitive to VSV infection and required higher does of IFN for protection (Fig. 3A) . In addition, 786-L188V cells were significantly more sensitive to the cytolytic effect of VSV than 786-Y112H cells (Fig. 3B) .
In a complementary experiment, pretreatment with chetomin, a small-molecule inhibitor of HIF-␣ activity (21), had a negligible effect on the response of 786-VHL cells to VSV (Fig. 4B , right panel) but dramatically enhanced the cytolytic effect of VSV on 786-O cells (Fig. 4B, left panel) . Notably, the effect of chetomin on HIF target genes, GLUT1 and EDN1, was confirmed by realtime qPCR (Fig. 4A) . In addition, 786-O subclones (shHIF-2␣-2 and shHIF-2␣-9) stably expressing shRNAs targeting HIF-2␣ were markedly more sensitive to VSV than cells expressing scrambled shRNA (Fig. 5B) . Real-time qPCR experiments confirmed the effective knockdown of HIF-2␣ in 786-O cells expressing shHIF-2␣ (Fig. 5A) . These results, taken together, suggest that VHL-mediated regulation of HIF is critical for the enhanced antiviral effect of RCC against VSV. In a complementary analysis to objectively evaluate the biological functions of the genes preferentially induced by VSV infection in 786-O cells, gene ontology (GO biological process) and Swiss-Prot (biological process and molecular function) annotations of the genes that showed at least twofold-greater induction by VSV in 786-O cells than in the 786-VHL counterpart (total of 121 genes) were analyzed using EASE (16) . The results, as summarized in Table 2 , clearly demonstrate a strong enrichment of genes involved in the immune and defense response, including the cellular response to virus. Moreover, the Swiss-Prot Biological Process and Molecular Function categories notably indicate overrepresentation of cytokines (for example, CXCl10, IL7, IFN␤, CXCl11, and TNFSF13B) and of genes involved in interferon induction, peptide transport, and transcriptional regulation (Tables 2  and 3 ).
The preferential induction of several ISGs (IFN␤, OAS1, and IFIT1) observed in the microarray experiment as showing the greatest degrees of change after VSV treatment was validated by real-time qPCR. 786-O and 786-VHL cells displayed similarly low levels of these genes in the absence of VSV infection and at 3 h postinfection (Fig. 7) . However, there was a dramatic induction of these genes in 786-O cells by 8 h post-VSV infection in comparison to levels in 786-VHL cells (Fig. 7) . Importantly, both IFN␤ and OAS1 have well-characterized antiviral functions (32) .
The functional involvement of IFN in the observed antiviral responses was confirmed by experiments using neutralizing antibody targeting IFN-␣/␤ receptor chain 2 (CD118). The neutralizing antibody sensitized 786-O cells to VSV in IFN protection assays at all doses of IFN-␣2b evaluated (Fig. 8A) . Consistently, the neutralizing antibody enhanced the sensitivity of 786-O cells to the cytolytic effect of VSV even in the absence of IFN pretreatment (Fig. 8B) . These results suggest that the protection against VSV-mediated killing observed in 786-O cells was due, at least in part, to IFN. Moreover, the sensitivity of 786-VHL cells in the presence of neutralizing antibody modestly increased the sensitivity to VSV as well (data not shown). Notably, while HIF enhances IFN production, it does not appear to affect cellular responses to exogenous IFN treatment (Fig. 9) . Specifically, the activation of STAT1 (as measured by Y701 phosphorylation) (Fig. 9A) 
DISCUSSION
HIF has been best studied for its role as a primary mediator of cellular responses to hypoxia. Pathological activation of HIF-␣ is observed in many forms of cancer and is recognized as being prognostic for a poor clinical outcome. HIF-␣-regulated genes have been implicated in promoting tumor progression and metastasis by enhancing angiogenesis, cell proliferation, and the resistance to apoptotic cell death (23) . Emerging evidence, however, suggests additional roles for HIF-␣ in host immune functions (12) . For example, HIF-␣ can be activated by a number of different cytokines, pathogen-associated molecular patterns, including LPS, or by infection with certain bacteria (31) . In addition, HIF-␣ has been shown to be activated upon infection with hepatitis B virus (41) and EpsteinBarr virus (38) . However, the impact of HIF-␣ activity on host cell responses to viruses had not been well studied.
Here, we have demonstrated that the loss of VHL enhances antiviral protection against VSV-induced cell death through a HIF-␣-dependent mechanism. 786-O cells, which are devoid of functional VHL, are more resistant to VSV than 786-VHL cells. Moreover, 786-Y112H cells, which express a mutant VHL with an impaired ability to target prolyl-hydroxylated HIF-␣, is similarly more resistant to VSV than 786-L188V cells, which express a mutant VHL that retains its ability to regulate HIF. The observation that chetomin, a small molecule inhibitor of HIF activity, increases the sensitivity of 786-O cells to VSV infection provides further support for the notion that HIF plays a critical role in the enhancement of the antiviral response. This was further confirmed by the increased susceptibility to VSV observed upon targeting of HIF-2␣ by RNA interference. Consistently, cobalt chloride, which stabilizes HIF-␣, promotes resistance against VSV-induced cytotoxicity in T98G glioblastoma cells.
In contrast to our findings demonstrating HIF-enhanced cellular resistance to VSV, Connor et al. showed that the virus replicated similarly under both hypoxic and normoxic conditions, although VSV replication was delayed in hypoxic tumor cells (7) . This would suggest that the expression of HIF does not correlate with viral replication. However, there are key differences between the study by Connor et al. and the present study. Whereas a low MOI of 0.1 for VSV was used in our experiments, the majority of the experiments by Connor et al. were conducted using a relatively high MOI of 10. Indeed, HeLa cells produced comparable virus titers irrespective of oxygen tension when challenged with VSV at an MOI of 10 (7). However, and consistent with our data, at a low MOI of 0.01, hypoxia significantly reduced the virus titer by 1 log (7). It is likely that a high dose of virus could overwhelm any antiviral effect mediated by HIF. Furthermore, the present study strictly addresses the role of HIF in the antiviral response, while Conner et al. examined the effect of hypoxia on the cytopathic effect and replication of VSV. It is reasonable to consider the possibility of other, yet-undefined factors induced during hypoxia that may have "masked" the effect of HIF.
The microarray and real-time qPCR analyses made in our Many of the immune response genes identified in our study are transcriptionally regulated by NF-B. For example, IFN␤, which was the most highly up-regulated gene transcript observed, is recognized as an NF-B-responsive gene (40) . Correspondingly, HIF has been shown to promote the activity of NF-B (2). However, our results demonstrate that HIF activity alone is insufficient to trigger NF-B-mediated activation of an IFN response, since in the absence of VSV infection, the expression levels of these genes were comparably low in both 786-O and 786-VHL cells. Only upon VSV infection were the levels of genes with known antiviral function dramatically upregulated in 786-O cells. In support of this notion, IFN␤ induction requires the transcription factor IRF3 in addition to NF-B (34) . Thus, VSV infection may activate additional transcription factor(s) that work in concert with HIF to trigger the antiviral response. The findings that neutralizing antibody to IFN-␣ enhanced cellular sensitivity to VSV indicate that IFN production played a functional role in the antiviral state observed in 786-O cells.
Collectively, our findings demonstrate a novel role for HIF as a modulator of the host cell innate immune response to virus infection via the enhancement of IFN and other gene transcripts involved in mediating the antiviral response. Our findings support a basis for investigating the application of modulators, specifically inducers, of HIF signaling as potential antiviral therapy.
